These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17325666)

  • 21. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and characterization of human acid sensing ion channel (ASIC)2 gene promoter.
    Xia J; Zhou ZH; Bubien JK; Fuller CM; Markert JM; Mapstone TB; Gillespie GY; Benos DJ
    Gene; 2003 Aug; 313():91-101. PubMed ID: 12957380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation.
    Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I
    Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
    Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
    Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
    Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
    Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene.
    Adimoolam S; Ford JM
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12985-90. PubMed ID: 12242345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
    Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
    Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.
    Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S
    Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.
    Yang J; Xu Z; Li J; Zhang R; Zhang G; Ji H; Song B; Chen Z
    J Urol; 2010 Jul; 184(1):336-43. PubMed ID: 20488473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
    Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
    Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene.
    Liang H; Lunec J
    Gene; 2005 Nov; 361():112-8. PubMed ID: 16202543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression.
    Tai KY; Shiah SG; Shieh YS; Kao YR; Chi CY; Huang E; Lee HS; Chang LC; Yang PC; Wu CW
    Oncogene; 2007 Jun; 26(27):3989-97. PubMed ID: 17213811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.